AstraZeneca admits Covishield can cause rare side effects Roshni Dhar1 May 2024 5:12 PM ISTAstraZeneca (AZ), a pharmaceutical giant headquartered in the UK, has acknowledged that in "very rare cases," its coronavirus vaccine can lead to a...
AstraZeneca admits 'very rare' side effect of COVID vaccine in UK court Ruchika Sharma30 April 2024 6:00 PM ISTLondon: AstraZeneca (AZ), a pharmaceutical giant headquartered in the UK, has acknowledged that in "very rare cases," its coronavirus vaccine can...
AstraZeneca-Oxford COVID vaccine faces legal challenge in UK, says Report Ruchika Sharma14 Nov 2023 4:15 PM ISTLondon: The Oxford-AstraZeneca COVID-19 vaccine, known as Vaxzevria in Europe and licensed as Covishield in India, is facing a legal...
AstraZeneca beats US shareholder lawsuit over COVID vaccine disclosures Ruchika Sharma13 Sept 2022 4:00 PM ISTUS District Judge Paul Oetken said AstraZeneca and its executives had no "generalized duty" to disclose "negative facts" about the trials.
AstraZeneca Covid jab Vaxzevria sales slide Ruchika Sharma1 Aug 2022 1:10 PM ISTThe group said annual revenue from Covid-19 medicines is anticipated to be broadly flat compared with 2021.
GSK, SK bioscience seek nod for SKYCovione in South Korea Ruchika Sharma1 May 2022 9:00 AM ISTSKYCovione is a self-assembled nanoparticle vaccine candidate targeting the receptor binding domain of the SARS-CoV-2 Spike protein for the parental...
Poorer nations refuse millions of AstraZeneca COVID vaccines from COVAX: Document Ruchika Sharma17 April 2022 9:00 AM ISTCountries declined to receive nearly 35 million AstraZeneca doses, opting to replace them with vaccines manufactured by Johnson and Johnson, Pfizer...
Very small blood clot risk after first AstraZeneca COVID dose, suggests Study MD Bureau24 Feb 2022 9:00 AM ISTStudy found no risk of major arterial and venous thrombotic events in those aged 70 or above with either of the vaccines.
Booster dose of AstraZeneca COVID vaccine effective against Omicron Ruchika Sharma23 Dec 2021 3:52 PM ISTUK: Citing the Oxford University lab study , drug major AstraZeneca has announced that the booster dose of the company's COVID vaccine Vaxzevria...
AstraZeneca Covid-19 vaccine shows 74 percent efficacy in US trial Ruchika Sharma2 Oct 2021 10:00 AM ISTChicago: AstraZeneca Plc's COVID-19 vaccine demonstrated 74% efficacy at preventing symptomatic disease, a figure that increased to 83.5% in people...
New brand names authorized for 3 Covid-19 vaccines in Canada, Details Medical Dialogues Team17 Sept 2021 2:18 PM ISTNew Delhi: Three approved Covid-19 vaccines manufacture by Pfizer-BioNTech , Moderna, and AstraZeneca will now be called Comirnaty, SpikeVax, and...
Covishield marketing authorisation will be considered when application is received: EU agency Ruchika Sharma29 Jun 2021 5:03 PM ISTNew Delhi: The Covishield vaccine "does not currently have a marketing authorisation" in Europe and the matter would be considered when an application...
